Abundant scores key e-commerce partnership to drive China sales
Abundant Natural Health (ANH) — a wholly owned subsidiary of Abundant Produce Limited (ASX:ABT) — has penned a pivotal e-commerce agreement with Hui Yi (Beijing) International Trade Co. Ltd to drive sales in China.
The agreement will expedite and encourage sales of ANH’s nutraceutical and cosmetic product ranges on Chinese e‐commerce giant, JD Global’s online platform, JD.hk.
Hui Yi will support ANH’s push into China by taking responsibility for the daily operations and maintenance of ANH’s online store on JD.hk.
Hui Yi has extensive experience within China in brand marketing and strategic activation, including sales channel management.
Hui Yi will work closely with ANH management to devise sales and marketing campaigns that clearly articulate the brand message and benefits across the entire ANH skincare and nutraceuticals range.
Running for an initial period of 12 months, the agreement will also see Hui Yi plan and execute promotional activities to drive traffic and conduct competitor brand and market analysis.
This will include promotion of ANH’s full range of ActiveLycoTM infused face products, magnesium-enriched nutraceuticals and salt skin cleansing gels to Chinese consumers on JD.hk.
The key extract which forms the basis of ANH’s ActiveLycoTM range is lycopene — a potent antioxidant which fights signs of aging, combats skin damage from sun exposure and provides relief from irritable skin conditions.
Launch of Abundant’s entire ANH-branded cosmetic and nutraceutical range on JD.hk is expected in the third quarter of 2018.
As China’s largest overall retailer in terms of revenue, JD Global offers ANH an unparalleled nationwide fulfilment network, with 486 warehouses servicing some 302 million active users.
However, growth is speculative and if considering this stock for your portfolio, you should take all public information into account and seek professional financial advice.
ANH CEO, Shanan Birkin, said: “Securing Hui Yi as our e-commerce partner represents a significant development for ANH, and for Abundant Produce more broadly. The agreement will accelerate our traction with customers through the largest online retail channel in the most exciting global market for organic cosmetics and nutraceuticals.”
“We are delighted that our innovative skincare offering is being recognised on an international level and look forward to growing sales rapidly in China with Hui Yi’s support,” said Birkin.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.